Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women

Agrawal S. et al, (2019), Hypertension

IFPA meeting 2018 workshop report II: Abnormally invasive placenta; inflammation and infection; preeclampsia; gestational trophoblastic disease and drug delivery

Albrecht C. et al, (2019), Placenta, 84, 9 - 13

Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia.

Cerdeira AS. et al, (2019), Hypertension (Dallas, Tex. : 1979), HYPERTENSIONAHA11912739 - HYPERTENSIONAHA11912739

Maternal circulating syncytiotrophoblast-derived extracellular vesicles contain biologically active 5'-tRNA halves.

Cooke WR. et al, (2019), Biochem Biophys Res Commun

Diagnostic utility of angiogenic biomarkers in pregnant women with suspected preeclampsia: A health economics review

Schlembach D. et al, (2019), Pregnancy Hypertension, 17, 28 - 35

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.

Winkler C. et al, (2019), Pediatr Diabetes

The role of angiogenic factors in the management of preeclampsia.

Flint EJ. et al, (2019), Acta Obstet Gynecol Scand, 98, 700 - 707

Placental Syncytiotrophoblast-Derived Extracellular Vesicles Carry Active NEP (Neprilysin) and Are Increased in Preeclampsia.

Gill M. et al, (2019), Hypertension (Dallas, Tex. : 1979), 73, 1112 - 1119

Circulating soluble fms-like tyrosine kinase-1 is placentally derived in normal pregnancy: First in vivo evidence.

Cerdeira AS. et al, (2019), Pregnancy Hypertens, 16, 145 - 147

Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting

Zeisler H. et al, (2019), Ultrasound in Obstetrics & Gynecology, 53, 367 - 375

Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21st Newborn Case-Control Study protocol

Kennedy SH. et al, (2019), Gates Open Research, 2, 49 - 49

Placental extracellular vesicles express active dipeptidyl peptidase IV; levels are increased in gestational diabetes mellitus.

Kandzija N. et al, (2019), J Extracell Vesicles, 8

Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia

Ukah UV. et al, (2019), Pregnancy Hypertension, 15, 42 - 50

Taming preeclampsia at its source

Cerdeira AS. and Vatish M., (2018), Nature Biotechnology, 36, 1151 - 1152

Consensus statement on the potential implementation of the sflt-1/plgf ratio in women with suspected pre-eclampsia

Matjila M. et al, (2018), South African Journal of Obstetrics and Gynaecology, 24, 61 - 65

Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21st Newborn Case-Control Study protocol

Kennedy SH. et al, (2018), Gates Open Research, 2, 49 - 49

Angiogenic factors: potential to change clinical practice in pre-eclampsia?

Cerdeira AS. et al, (2018), BJOG: An International Journal of Obstetrics & Gynaecology, 125, 1389 - 1395

CIRCULATING SFLT-1 IS PLACENTALLY DERIVED IN NORMAL PREGNANCY

Cerdeira AS. et al, (2018), PLACENTA, 69, E48 - E48

CIRCULATING SYNCYTIOTROPHOBLAST-DERIVED EXTRACELLULAR VESICLES EXHIBIT VARIATION IN RELEASE BETWEEN NIGHT AND DAY

Cooke W. et al, (2018), PLACENTA, 69, E47 - E48

COL17A1 IS A SYNCYTIAL TROPHOBLAST EXTRACELLULAR SPECIFIC MARKER SIGNIFICANTLY ELEVATED IN PREECLAMPSIA

Zhang W. et al, (2018), PLACENTA, 69, E41 - E41

Load More

Include forthcoming?